Improvements in Lung Function Outcomes in Children with Cystic Fibrosis are Associated with Better Nutrition, Fewer Chronic Pseudomonas aeruginosa Infections, and Dornase Alfa Use

This publication has 22 references indexed in Scilit:

• Clinical Use of Ibuprofen Is Associated with Slower FEV₁ Decline in Children with Cystic Fibrosis
  American Journal of Respiratory and Critical Care Medicine, 2007
• Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
  The Journal of Pediatrics, 2007
• Improving rate of decline of FEV1 in young adults with cystic fibrosis
  Thorax, 2006
• Standardisation of spirometry
  European Respiratory Journal, 2005
• DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: Influence of treatment with dornase alpha
  Pediatric Pulmonology, 2004
• Predictors of deterioration of lung function in cystic fibrosis*
  Pediatric Pulmonology, 2002
• A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities
  The Journal of Pediatrics, 2001
• Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1994
• Pulmonary function between 6 and 18 years of age
  Pediatric Pulmonology, 1993
• Prediction of Mortality in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1992